⌘K

Login Start Free

Home/Filings/4/0000313143-12-000059

4//SEC Filing

Gordon Mikael 4

Accession 0000313143-12-000059

CIK 0000313143other

View on SEC.gov Company Profile

Filed

May 2, 8:00 PM ET

Accepted

May 3, 3:18 PM ET

Size

27.1 KB

Accession

0000313143-12-000059

Insider Transaction Report

Form 4

Period: 2012-05-02

HAEMONETICS CORPHAE

President, Haemonetics Europe

Transactions

Sale
Common Stock
2012-05-02$71.87/sh−4,735$340,318→ 4,442 total
Sale
Common Stock
2012-05-02$71.88/sh−228$16,388→ 6,610 total
Sale
Common Stock
2012-05-02$71.87/sh−9,793$703,851→ 6,610 total
Sale
Common Stock
2012-05-02$71.87/sh−6,980$501,673→ 4,442 total
Exercise/Conversion
Common Stock
2012-05-02$52.94/sh+9,793$518,441→ 16,403 total
Sale
Common Stock
2012-05-02$71.94/sh−2,168$155,963→ 4,442 total
Sale
Common Stock
2012-05-02$71.87/sh−11,435$821,867→ 4,442 total
Exercise/Conversion
Common Stock
2012-05-02$54.55/sh+11,435$623,779→ 15,877 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-05-02$71.87/sh−9,793$703,851→ 9,794 total
Exercise: $52.94From: 2010-10-27Exp: 2016-10-27→ Common Stock (9,793 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-05-02$71.87/sh−11,435$821,867→ 3,812 total
Exercise: $54.55From: 2009-10-22Exp: 2015-10-22→ Common Stock (11,435 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-05-02$71.87/sh−6,980$501,673→ 8,000 total
Exercise: $55.14From: 2009-01-22Exp: 2015-01-22→ Common Stock (6,980 underlying)
Exercise/Conversion
Common Stock
2012-05-02$54.99/sh+4,735$260,378→ 9,177 total
Exercise/Conversion
Common Stock
2012-05-02$55.14/sh+6,980$384,877→ 11,422 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-05-02$71.87/sh−4,735$340,318→ 14,205 total
Exercise: $54.99From: 2011-10-27Exp: 2017-10-27→ Common Stock (4,735 underlying)

Holdings

Non-Qualified Stock Option (right to buy)
Exercise: $61.34From: 2012-10-25Exp: 2018-10-25→ Common Stock (17,565 underlying)
17,565

Footnotes (2)

[F1]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
[F2]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1

filerCIK 0001418808

Filing Metadata

Form type: 4
Filed: May 2, 8:00 PM ET
Accepted: May 3, 3:18 PM ET
Size: 27.1 KB

View on SEC.gov